NON-EXCLUSIVE LICENSE AGREEMENT (#1) FOR SOLVENT DETERGENT TREATED BLOOD DERIVED THERAPEUTIC PRODUCTS between THE NEW YORK BLOOD CENTER, INC. and MELVILLE BIOLOGICS, INC. ------------------------V I Technologies Inc • March 12th, 1998 • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.39 ----- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. THIS AGREEMENT dated 4 May 2001 (the "EFFECTIVE DATE") is made BETWEEN: (1) ISIS INNOVATION LIMITED,...Agreement • November 13th, 2001 • V I Technologies Inc • Biological products, (no disgnostic substances)
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 13th, 2002 • V I Technologies Inc • Biological products, (no disgnostic substances)
UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • June 5th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
andAsset Purchase Agreement • August 28th, 2001 • V I Technologies Inc • Biological products, (no disgnostic substances)
WHEREAS, Vitex and Bayer entered into a First Amended and Restated Agreement for Custom Processing dated January 24, 1996 (the "Custom Processing ----------------- Agreement"), pursuant to which Bayer agreed to supply plasma to Vitex and Vitex...Settlement Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
Page SECTION 1. DEFINITIONS..................................................... 1 1.1 Defined Terms...................................................... 1 1.2 Other Definitional Provisions...................................... 16 SECTION 2. AMOUNT...Credit Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
PARTIESEmployment Agreement • February 26th, 1998 • V I Technologies Inc • New York
EXHIBIT 2.1 ------------Agreement and Plan of Merger • November 10th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.42 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. MARKETING RIGHTS, DEVELOPMENT, ROYALTY, REVOLVING CREDIT AND SECURITY AGREEMENTAssignment Agreement • August 13th, 2002 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 4.4 THIS WARRANT AND THE SECURITIES REPRESENTED BY THIS WARRANT HAVE BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER ANY APPLICABLE STATE...V I Technologies Inc • February 26th, 1998 • New York
Exhibit 10.1 ------------ SEPARATION AGREEMENT AND GENERAL RELEASE ---------------------------------------- Separation Agreement and General Release ("Agreement") executed this ___ day of September 1999, by and between Bernard Horowitz, Ph.D. ("Dr....Separation Agreement • November 15th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
RECITALSSublease Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances)
WITNESSETH: ---------- WHEREAS, pursuant to the Credit Agreement, dated as of December 22, 1997 (the "Credit Agreement"), between the Company and Chase, Chase has agreed to make a term loan (the "Chase Term Loan") in the principal amount of...Intercreditor Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
MODIFICATION AGREEMENT ----------------------Modification Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
NON-EXCLUSIVE LICENSE AGREEMENT (#2) FOR UV TREATED BLOOD DERIVED THERAPEUTIC PRODUCTS between THE NEW YORK BLOOD CENTER, INC. and MELVILLE BIOLOGICS, INC. -----------------------------------------V I Technologies Inc • March 12th, 1998 • Biological products, (no disgnostic substances) • New York
LEASE BetweenV I Technologies Inc • March 12th, 1998 • Biological products, (no disgnostic substances)
BY AND AMONGAgreement and Plan of Merger and Reorganization • October 7th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • Delaware
SECURITY AGREEMENT ------------------ THIS AGREEMENT is made and entered into as of this 22d day of December, 1997, by and between V.I. Technologies, Inc. (formerly known as Melville Biologics, Inc.), a Delaware corporation with offices at 155 Duryea...Security Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • Pennsylvania
EXHIBIT 10.34 OPTION, DEVELOPMENT, MANUFACTURE AND LICENSE AGREEMENTLicense Agreement • October 7th, 1999 • V I Technologies Inc • Biological products, (no disgnostic substances) • Massachusetts
REGISTRATION RIGHTS AGREEMENT dated February 19, 1998, among V.I. TECHNOLOGIES, INC., a Delaware corporation (the "Company"), and the stockholders of the Company listed on Schedule I (the "Investors").Registration Rights Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
indicates material omitted and filed separately with the Securities and Exchange Commission Pursuant to a request for confidential treatment.] second installment of ***************************** due no later than April 1, **** and a Third Installment...Exclusive License Agreement • March 31st, 2000 • V I Technologies Inc • Biological products, (no disgnostic substances)
made byGuarantee and Collateral Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.31 MORTGAGE AND SECURITY AGREEMENTMortgage and Security Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.33 V.I. TECHNOLOGIES, INC. INDEMNIFICATION AGREEMENT ------------------------- This Agreement dated ______________________ is between V.I. Technologies, Inc. (the "Company"), a Delaware corporation, and ______________________ (the...Indemnification Agreement • February 26th, 1998 • V I Technologies Inc • Delaware
AGREEMENT ---------Agreement • February 26th, 1998 • V I Technologies Inc
RECITALSLease Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances)
EXCLUSIVE DISTRIBUTION AGREEMENT BY AND BETWEEN V.I. TECHNOLOGIES, INC. AND UNITED STATES SURGICAL CORPORATION EFFECTIVE OCTOBER 4, 1996Exclusive Distribution Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • Connecticut
EXHIBIT 10.14 -------------Omnibus Agreement • March 31st, 2000 • V I Technologies Inc • Biological products, (no disgnostic substances)
BETWEENMarketing and Distribution Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
STOCK PURCHASE WARRANT To Purchase Shares of Common Stock ofV I Technologies Inc • December 15th, 2003 • Biological products, (no disgnostic substances)
THIS STOCK PURCHASE WARRANT CERTIFIES that, for value received, $ (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 5, 2003 (the “Initial Exercise Date”) and on or prior to the close of business on December 5, 2007 (the “Termination Date”) but not thereafter, to subscribe for and purchase from V.I. Technologies, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $1.32, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certa
SUFFOLK COUNTY INDUSTRIAL DEVELOPMENT AGENCY (SUFFOLK COUNTY, NEW YORK) andFacility Lease Agreement • March 12th, 1998 • V I Technologies Inc • Biological products, (no disgnostic substances)
DEVELOPMENT AND SUPPLY AGREEMENT BETWEEN V.I. TECHNOLOGIES, INC. AND HAEMONETICS CORPORATIONV I Technologies Inc • November 13th, 2001 • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE ---------------------------------------- Separation Agreement and General Release ("Agreement") executed this ___ day of September 1999, by and between Bernard Horowitz, Ph.D. ("Dr. Horowitz" or...Separation Agreement and General • February 22nd, 2000 • V I Technologies Inc • Biological products, (no disgnostic substances) • New York
